<?xml version="1.0" encoding="UTF-8"?>
<ref id="b116-ir-2019-09155">
 <label>116</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Phipps</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>D</given-names>
   </name>
  </person-group>
  <article-title>Lymphoproliferative disease and hepatitis B reactivation: challenges in the era of rapidly evolving targeted therapy</article-title>
  <source>Clin Lymphoma Myeloma Leuk</source>
  <year>2016</year>
  <volume>16</volume>
  <fpage>5</fpage>
  <lpage>11</lpage>
  <pub-id pub-id-type="pmid">26705677</pub-id>
 </element-citation>
</ref>
